อดาแล็ง

Adalank is a synthetic peptide analogue of selank, with targeted chemical alteration.

 

 

แบ่งปันความรักของคุณ

Adalank is a synthetic peptide analogue of selank, with targeted chemical alteration.

The peptide is designed as a อนุพันธ์ ของ nootropic drug Selank, with the addition of an acetylated N-terminal function that enhances its adamantane-like sterically-constraining structure.

This modification acts as a powerful synergistic potentiator of the anxiolytic – nootropic compound Selank.

It circumvents Selank’s poor อุปสรรคเลือดสมอง (บีบีบี) การเจาะ, thereby increasing the central nervous system activity of Adalank significantly.

The addition of an acetyl group eliminates the positive charge of the N-terminal free amino group and decreases the net charge of the peptide.

This physicochemical adjustment optimizes the isoelectric point and surface properties of Adalank, reducing non-specific electrostatic interactions.

ส่งผลให้, the drug molecule crosses the blood–brain barrier more easily and reaches the central nervous system.

นอกจากนี้, อะซิติเลชั่น protects Adalank from exopeptidase degradation and significantly increases its in vivo half-life.

This provides the advantage of prolonged therapeutic blood levels and reduces frequent dosing.

The inclusion of adamantane creates a stable “conformation core” in the Adalank peptide.

This imparts a fixed spatial orientation to the initially flexible linear peptide, promoting the stereochemical conformation necessary for biological activity even in its unbound state.

This greatly improves Adalank’s ability to cross the blood-brain barrier.

In addition, Adalank exhibits certain immunomodulatory effects.

ลำดับ

ac-thr-lys-pro-arg-pro-gly-pro-Adamantane-nh2

หมายเลข CAS

/

สูตรโมเลกุล

C46H75N13O10

น้ำหนักโมเลกุล

970.19

Research Of Adalank:

1.กลไกการออกฤทธิ์

Efficacy-wise, Adalank’s rigid structure more closely corresponds to the allosteric modulation site of the GABA_A receptor alpha subunit, imparting stronger anxiolytic effects.

Moreover, the adamantane moiety enables hydrophobic interactions in the ตัวรับ NMDA channel area to moderate calcium influx and protect against excitotoxic injury.

This property has the potential for neuroprotection in models of ischemic brain injury and post-traumatic stress disorder (พล็อต).

2.Anxiolytic Effects

As an optimized derivative of Selank, Adalank maintains a high-affinity interaction with the benzodiazepine site on the GABA_A receptor α-subunit.

อย่างไรก็ตาม, the N-terminal acetylation and adamantane scaffold shift the binding mode from “flexible induced fit” to “rigid precise docking”.

This enhances GABAergic inhibitory neurotransmission, promoting chloride influx and rapid reduction of activity in hyperactive amygdala-prefrontal cortex neural circuits.

In contrast to benzodiazepines, Adalank shows high receptor subtype selectivity, enabling sustained anxiolytic effects without the sedation, muscle relaxation, or addiction potential associated with traditional drugs.

Its therapeutic index is 3 ถึง 5 times wider, supporting long-term management of generalized anxiety disorder and situational anxiety disorders.

3.Cognitive Enhancement and Memory Improvement

Adalank effectively inhibits the activation of the NF-κB inflammatory pathway and increases บีดีเอ็นเอฟ mRNA expression by 50%-80% in the hippocampus.

This leads to activation of downstream Akt/CREB เส้นทางการส่งสัญญาณ, facilitating LTP induction and maintenance.

It significantly improves memory retention in passive avoidance tests, enhances spatial learning in the Morris water maze, and counteracts scopolamine-induced cholinergic damage.

Preclinical data indicate that Adalank reduces working memory errors by 40%-60% and mitigates natural memory decline in aged animals, suggesting applicability in learning disorders, mild cognitive impairment, and age-related memory decline.

4.ผลป้องกันระบบประสาท

The adamantane structure in Adalank mimics the action of memantine, acting as a non-competitive ตัวรับ NMDA antagonist that causes voltage-dependent blockade of open channels and physiological regulation of calcium influx.

It reduces pathological Ca²⁺ influx by 60–70% without impairing physiological synaptic Ca²⁺ signaling, achieving a selective neuroprotective profile without disrupting normal function.

ดังนั้น, preclinical studies highlight Adalank’s significant translational potential for early intervention in acute stroke, spinal cord injury, และ โรคทางระบบประสาท.

COA

HPLC

นางสาว

(1) Doyno, ค. ร.; สีขาว, ค. ม. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. J Clin Pharmacol 2021, 61 Suppl 2, S114-S128. ดอย: 10.1002/jcph.1922 From NLM M

(2) Kasian, ก.; Kolomin, ต.; แอนดรีวา, ล.; บอนดาเรนโก, อี.; มีอาโซดอฟ, เอ็น.; Slominsky, ป.; Shadrina, ม. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol 2017, 2017, 50910

(3) Kolik, ล. ช.; Nadorova, ก. วี.; Antipova, ต. ก.; Kruglov, ส. วี.; กุดริน, วี. ส.; Durnev, ก. ดี. เซลังค์, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex

(4) Kolik, ล. ช.; Nadorova, ก. วี.; Seredenin, ส. บี. Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice. Bull Exp Biol Med 2016, 162 (1), 56-59. ดอย: 10.1007/s10517-016-3544-6 From NLM Medline.

(5) ค่าใช้จ่าย, เอ็น. วี.; โซโคลอฟ, โอ; กาบาเอวา, ม. วี.; กรีเวนนิคอฟ, ฉัน. ก.; แอนดรีวา, ล. ก.; มีอาโซดอฟ, เอ็น. เอฟ; โซซูเลีย, ก. ก. [Semax และ selank ยับยั้งเอนไซม์ที่ย่อยสลายเอนเคฟาลินจากซีรั่มของมนุษย์]]. บิออร์ก คิม 2001, 27 (3), 180-183. ดอย: 10.1023/ก:10113730028

(6) Neznamov, ช. ช.; Teleshova, อี. ส.; Bochkarev, วี. เค.; Koschelev, วี. วี.; Syunyakov, ต. ส. P.3.036 Novel anxiolytic Selank: Results of thePhase II clinical trials. European Neuropsychopharmacology 2005, 15, S159-S160. ดอย: 10.1016/s0924-977x(05)80332-3.

(7) Slominsky, ป. ก.; Shadrina, ม. ฉัน.; Kolomin, ต. ก.; Stavrovskaya, ก. วี.; Filatova, อี. วี.; แอนดรีวา, ล. ก.; Illarioshkin, ส. เอ็น.; มีอาโซดอฟ, เอ็น. เอฟ. Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. Dokl Biol Sc

(8) Sollertinskaja, ต. เอ็น.; Shorochov, ม. วี.; มีอาโซดอฟ, เอ็น. เอฟ. The cerebroprotective effects of Semax and Selank in primates at different types of neurosis. International Journal of Psychophysiology 2008, 69 (3). ดอย: 10.1016/j.ijpsycho.2008.05.356.

ลำดับ:

ac-thr-lys-pro-arg-pro-gly-pro-Adamantane-nh2

CAS:

ไม่มี

เมกะวัตต์:

970.19 กรัม/โมล

บ้าน ค้นหา วอทส์แอพพ์ บริการ ผลิตภัณฑ์